The end of this excellent presentation by Dr. Katie Pratt concisely details the attributes of science storytelling and shows the final product in a video that condenses two months on an Antarctic icebreaker into less than five minutes.
The end of this excellent presentation by Dr. Katie Pratt concisely details the attributes of science storytelling and shows the final product in a video that condenses two months on an Antarctic icebreaker into less than five minutes.
I originally wrote this remembrance of my high school classmate 10 years ago, on September 11, 2006, at Terra Sigillata on ScienceBlogs.com. It has appeared in various forms on several sites, but this is the only place where you can still share your comments.
Let me tell you about John Michael Griffin, Jr.
Griff, as he was known in high school, was a friend of mine.
Late in the first half of our lives, he stood up for me physically and philosophically, for being a science geek. John’s endorsement was the first time I was ever deemed cool for wanting to be a scientist.
Griff died an engineer and hero in the collapse of one of the World Trade Center towers five  years ago today.
We lost touch almost twenty years before, but his kindness and friendship formed not only one of the cornerstones of the scientific life I have today, but in the person and father I have become as well.
At a northern New Jersey Catholic high school in a predominantly Irish town, being a gangly Polish boy from two towns over was not the formula to cultivate one’s popularity or self-preservation.
Throwing the curve in biology and chemistry classes didn’t help either, nor did being a David Bowie fan in a place where Bruce Springsteen was as revered as St. Patrick. That’s probably where the nickname, “Zowie,” came from – the name of the glam rocker’s first child.
Worse, I had skipped a grade in elementary school, and being a year behind physically was not compatible with self-preservation during high school gym class.
But, it was a very simple gesture, sometime in junior year, when one of the packs of scoundrels had me cornered, slamming me against the wall and throwing my books down the hallway. I believe that the offense was that our biology teacher had taken to buying me a Pepsi every time I scored 100 on one of his exams, and I had been enjoying yet another one.
John, already well on his way to his adult height of 6′ 7″ or 6′ 8″, stepped in and said, “Hey, lay off of Zowie. He’s goin’ places.” And with that, the beatings stopped.
I didn’t play sports, at least not any of the ones offered by our school. At that time, soccer hadn’t taken off in the States but I was a huge player and had met John at Giants Stadium in the NJ Meadowlands where I had season tickets (Section 113, row 7, seat 26) for the relocated New York Cosmos. At just $4 a ticket for kids 16 and under, I could afford season tickets to see some of the greatest international soccer stars of the late 20th century: Germany’s Franz Beckenbauer, Italy’s Giorgio Chinaglia, Yugoslavia’s Vladislav Bogiçeviç, and, of course, Brazil’s great Pelé.
All accounts of John as an adult include his devotion to the Giants, NY Rangers, and NY Yankees, but few recall those soccer days. John’s family were long-time Giants season ticket holders and probably got their Cosmos season tickets three rows behind me as some sort of promotional giveaway. I recall that John was surprised that a science dork such as I would be cool enough to know about soccer and come to games myself, my father dropping me off outside the gates so he could go home and watch his beloved football games.
But, we Jersey boys loved soccer at a school where American football and basketball reigned supreme. Many Saturday and Sunday afternoons were spent at the massive stadium during soccer’s American heyday of the late 1970s, with crowds of 50,000 – 75,000 that have yet to be matched today.
Among John’s gifts was the ability to make anything fun and to make anyone laugh. I recall sitting with him in a ski lodge in Amsterdam, NY, as I was recovering from frostbite during an ill-prepared class trip ski weekend. He pulled me into an imaginary board game with a napkin dispenser, where he pretended each napkin contained a message as to how to proceed during each turn. We looked at each other in horror when the waitress came unannounced and cleared our table of the napkins.
As a teenager, John was a physical caricature, handsome but a goof, self-effacing but self-confident, and had a clever and caustic wit, both of which he carried into adult professional life and fatherhood. His 15 Sept 2001 missing notice in the Bergen (NJ) Record noted that schoolkids called him, “Barney,” to reflect how they flocked to his presence.
No one was safe from John’s good-hearted and bombastic comedy routines. My father was nicknamed, “Groucho,” by John due to the resemblance of his thick mustache to that of the 1930’s comedian – John would burst spontaneously into seemingly classic Marx Brothers riffs, but with the content imitating my father carrying on about some printing press mishap.
My last remembrances of John are half a life away, from the impromptu high school graduation party he called at my house to his pride at finishing his engineering degree and managing facilities for a million-square foot building in Manhattan.
Perhaps he protected me as a kid because he knew that way deep down, he was destined to become an engineering geek himself. And a hero, a much bigger hero, in protecting the lives of others in a very real way.
On the glorious fall morning of 11 Sept 2001, I was fixing coffee for my wife who had been sleeping in when the newsreader on my pager announced that a jet had struck the south tower of the World Trade Center.
I had missed my recent 20-year high school reunion and had not known that John had only months before been appointed director of operations at the WTC by Larry Silverstein’s, Silverstein Properties.
I did not learn until two weeks later that John had facilitated the escape of dozens of workers, handing out wet towels so people could breathe on their way down the stairs. In the 102 Minutes book by New York Times writers Jim Lynch and Kevin Flynn, John is immortalized in the corroborated account of the elevator rescue of 72-year-old Port Authority construction inspector, Tony Savas.
When he returned to 78, Greg Trapp saw a group of three Port Authority employees at work on the doors to the elevator where Tony Savas, a seventy-two-year-old structural inspector, was trapped. Trapp peered into the small gap and saw him, a man with thinning white hair, seemingly serene. One of the workers grabbed a metal easel, wedging the legs into the opening, trying to spread the doors from the bottom, where they seemed to have the greatest leverage. But their efforts had the opposite effect at the top of the doors, which seemed to pinch tighter.
At that moment, John Griffin, who had recently started as the trade center’s director of operations, came over to the elevator bank. At six feet, eight inches tall, Griffin had no problem reaching the top of the door to apply pressure as the others pushed from the bottom. The doors popped apart. Out came Savas, who seemed surprised to find Griffin, his new boss, involved in the rescue. Savas seemed exhilarated, possessed of a sudden burst of energy, rubbing his hands together, or so it seemed to Trapp.
“Okay,” Savas said. “What do you need me to do?”
One of the Port Authority workers shook his head. “We just got you out-you need to leave the building.”
No, Savas insisted. He wanted to help. “I’ve got a second wind.”
John and Mr. Savas stayed behind.
John’s wife, June, sweetheart of the class behind us, was quoted in John’s NYT, Portraits of Grief:
“He was at the back of about 30 people they were evacuating,” his wife, June Griffin, related from the accounts of survivors. “He had been in fires before — he should have gotten out.”
Mrs. Griffin speculated that her husband, instead of running for the exits, headed for the fire control center, where his training as a fire safety officer would have directed him. “He was an engineer,” Mrs. Griffin said. “He must have thought, ‘Buildings don’t just fall down.’”
John also left two daughters, both now teenagers, his parents, a younger brother and older sister, and literally hundreds of friends.
Not just any friends, either – anyone who knew John still says that when he talked with you, it was as though you were the most important person in the world.
Leaving New Jersey in the mid-1980s and running on the tenure-track treadmill 1,600 miles away caused me to stop living life and lose track of a great many friends. I am deeply saddened not to have known John as an adult, a devoted husband and, by all accounts, a remarkable father.
Since John’s death, we’ve all found a little more time in our schedules to make time for one another. As the father of a little girl conceived in the months after the terrorist attacks, I try to respect June’s privacy and just send little gifts for the girls every so often. I cannot imagine how they and nearly 3,000 other families deal privately with the most public of tragedies.
I finally worked up the guts to go to Ground Zero [ten years and] two months ago for the first time. Despite all the bickering about what the memorial should look like, there is a small memorial area set up in the interim. John’s name sits at the top of one column of names on the placards commemorating those lost.
He’ll always be at the top of my list.
This picture also appeared in 2011 when John’s younger daughter, Julie, now 20, was interviewed for the Waldwick (NJ) Suburban News by Jody Weinberger.
Julie’s memory of the events that took place on 9/11 is spotty. She was a fourth-grader at Crescent Elementary School when relatives came to take her and Jenna home.
“It was kind of chaotic,” Julie recalls, sitting on a stool in her kitchen. “Even though people were saying things, I didn’t know what they were talking about. I didn’t know what terrorism was and not even adults could really grasp what was happening.
“My grandpa came up to me and told me bad people did something to where my dad worked and that’s all I could really grasp at the time.”
After discussing her father’s rescue of Mr. Savas, Julie shared more of her mixed feelings:
“But then I think he actually went back to help more people and I think that’s when the buildings collapsed,” Julie said. “I was kind of angry knowing that he went to go save other people instead of thinking about coming home to his family. That bothered me but now I know he’s a hero.”
As the 10th anniversary of 9/11 approaches, Julie thinks about just some of the many moments she’s missed not having her father around.
“People think that it’s just the anniversaries, birthdays and holidays, and it’s true, those really are hard times, but every day [you have to] keep your head up and think positive,” she said. “It’s little things like learning how to drive and applying for college, or my first day of college that you just kind of wish he was there for, and you just have to keep going, I guess.”
Julie feels that by going after her dreams – which currently means graduating from the University of Tampa and pursuing a career in elementary education – she is making her father proud.
That Facebook post from June was from 2012. In 2013, we heard directly from Julie Griffin in a brave article she wrote for the national website of Kappa Alpha Theta, “Overcoming tragedy with the help of my sisters.”
Postscript – 2016
Next Friday, September 16, 2016, many of us are gathering at St. Mary High School in Rutherford, New Jersey for Griff Rocks On, an annual fundraiser to honor our fallen hero that provides tuition assistance for SMHS students in need. June, my sister, Sandi, and my classmates have formally established John Griffin 9/11 Foundation as a 501(c)(3) organization. We’d love to have any of you attend, celebrate John’s life and dance and sing to the B Street Band, a Bruce Springsteen cover band. Regardless, and if you’re so inclined, tax-deductible donations can be made to the Foundation at the PayPal button below. For more information, please visit GriffRocksOn.org.
I had the honor of speaking to a science communications seminar class at the North Carolina School of Science & Mathematics, recently described by Dave Dewitt at our NPR affiliate as, “[C]reated 35 years ago for serious NC students with grand aspirations. It was the first residential school of its kind in the country, and it’s public. The course catalog rivals many major universities, with classes in robotics, biomedical engineering, and astrophysics.”
Dean of Science, Dr. Amy Shenk, invited me to talk about the Ebola Virus Disease outbreak ongoing in west Africa in terms of its challenges to public science communication. I’ve put together my collection of stories written in my role as a contributor to the Pharma & Healthcare section of Forbes.com. With my training as a pharmacologist, I naturally focus on what drugs are in development to treat the potentially fatal disease. But what I’ve learned is that drugs have little use if a health system lacks infrastructure to even monitor blood or administer intravenous electrolytes.
General thought questions
What do you know about Ebola hemorrhagic fever (now called Ebola Virus Disease, or EVD)?
What were you thinking when news of the outbreak first broke?
What did you think about bringing infected U.S. missionaries to Atlanta for care?
What message might this send to the people of west Africa?
Where did science communication go wrong? Where did it go right?
For the following articles:
Which of these do you think have particularly high value (or low value!) in communicating the complexity of the Ebola situation to the general public.
Does the simple listing of facts lead to understanding, addressing legitimate concerns?
What ethical issues does the use of experimental Ebola drugs raise that present a general science communication opportunity?
Kroll Ebola articles at Forbes
Do We Have Any Drugs To Treat Ebola? – 29 July 2014
Ebola ‘Secret Serum’: Small Biopharma, The Army, And Big Tobacco – 5 August 2014
FDA Moves On Tekmira’s Ebola Drug While Sarepta’s Sits Unused – 7 August 2014
Beware Of Fake Ebola Supplements – 14 August 2014
How Will We Know If The Ebola Drugs Worked? – 26 August 2014
NIAID/GSK Ebola Vaccines To Enter US, UK Human Safety Trials – 28 August 2014
WHO Ebola Drug Panel: Use Survivor Serum To Treat Ebola Victims – 5 September 2014
Gates Foundation Commits $50 Million To Ebola Containment Efforts – 10 September 2014
Cuba Responds To Ebola Crisis As Black Market For Convalescent Serum Emerges – 12 September 2014
CDC Ramps Up Ebola Worker Training In Advance Of Obama Announcement – 16 September 2014
Explaining the drugs, informed consent
Ebola, Experimental Drugs and Informed Consent: Should Those At Risk Simply Take The Doctors Orders? – by Elaine Schattner – 31 August 2014
Vaccines and public health – Another science communications challenge
Final, somewhat unrelated issue on science communications relative to tomorrow’s NOVA documentary on vaccines: The need for humility in public health communications, by Dr. Brian Zikland-Fisher of the University of Michigan. The polarization of vaccine attitudes, regardless of scientific facts, requires a middle ground where people can have legitimate concerns addressed.
We must acknowledge that each parent has the right and the authority to make his or her own choices, and that it is our failing (either in the quality of our vaccines or the persuasiveness of our message), not theirs, if we have failed to convince them that vaccination is the better choice.
We must acknowledge that we have the best chance of convincing a skeptical public when we put the weaknesses of our arguments and the risks of our interventions front and center and acknowledge the fears that they evoke.
It may seem counterintuitive, but embracing humility may be the best thing we can do. Humility will build trust in those who believe (sometimes accurately) that we are not telling the whole story. Humility might resonate with those parents who genuinely want to do right by their children but have not been convinced by “the facts.”
I’m excited to announce that my 2014 spring tour of the three-county, Research Triangle region will kick off this Friday night at Intrepid Life Coffee & Spirits on Historic West Parrish Street in downtown Durham. I’ll start around 9:00 pm and play two, 75-minute sets.
I’ll be playing many of your old Dogs in the Yard classics from my band in Denver as well as some new and not-so-new original compositions. I’ve also gotten really excited about playing other great local music I’ve heard around the Triangle and on my last trip to Denver for the Association of Health Care Journalists meeting in late March (where I also had a nice night of jamming with Dan and Jay from the Dogs).
I’m particularly excited to be playing at Intrepid Life, my go-to coffee shop for business meetings in Durham. You’ve probably heard the story about the owner, Matt Victoriano, a Marine combat veteran who served two tours in Iraq.
He was first interviewed by WBUR’s Here and Now in Charlotte at the 2012 Democratic National Convention, where he had visions of opening a brewpub. Plans changed – not the least of it due to the challenges of small business loans for returning veterans – and we were fortunate that he chose Durham to open Intrepid Life Coffee & Spirits Bar.
The updated version of Matt’s story came earlier this year when Here and Now’s Robin Young caught up with him to check in. When I heard this story, I was impressed that the owner of Joe Van Gogh coffee roasters in Hillsborough loaned Matt equipment to get the place off the ground, instead of just thanking him for his service to the country.
So I emailed Matt when he opened the place and offered to play for free pretty much anytime to do my part to support his mission to advocate for veterans and progressive non-profits in his community space. Editor Lisa Sorg describes the vibe perfectly in her INDY Week piece last month.
So even if you don’t come to hear my sets, I encourage you to drop by Intrepid Life this Friday night, or anytime. If you can’t find street parking, you can try the city lot by Rue Cler and the Post Office, then just walk through Orange Street past Phoebe Lawless’s Scratch bakery.
I have a soft spot for people with the guts to volunteer their lives to serve in the military for this country. My Dad was a Marine and Heather’s been working at the VA hospital in Durham for almost two years. And my longtime Texas songwriting idol, Darden Smith, has been using his musical prowess to help veterans process their emotions through songwriting retreats – a project appropriately called SongwritingWith:Soldiers.
Matt has made an investment in our community so I hope that we can all make an investment in him – and in downtown Durham.
C&EN is a weekly publication of the American Chemical Society, the world’s largest scientific society that counts 161,000 members across chemistry-related disciplines. Their blog, C&ENtral Science was retooled last March to establish seven blogs written by several C&EN editors and staff writers.
The CENtral Science blogs and their descriptions are as follows:
Cleantech Chemistry by Melody Voith with Alex Tullo
The Cleantech Chemistry blog will take a close look at the business and technology strategies of a number of companies – many of them new – that hope to serve the world’s need for renewable energy, sustainable agriculture, clean water, and non-polluting manufacturing and transportation, among other cleantech sectors.
Just Another Electron Pusher by Leigh Krietsch Boerner
Just Another Electron Pusher will keep you informed about non-traditional careers in chemistry. Here we talk to people who’ve pursued professions away from the bench about what they do and how they got there. We’ll also follow our blogging heroine in her quest for a satisfying job that uses her degree, but doesn’t involve running any %$@& columns.
Newscripts by Lauren Wolf, Bethany Halford, and Rachel Pepling
“Newscripts” is the companion blog to the like-named weekly C&EN column. Here you’ll find even more quirky news nuggets plus videos, polls, and photo galleries.
The Chemical Notebook by Alex Tullo with Melody Voith
The name directly encapsulates what the blog is meant to be. The topic is the chemical industry: those companies such as Dow, ExxonMobil, BASF, and DuPont that are engaged in the chemical transformation of one molecule to another as of part of a manufacturing stream that ultimately results in products suitable for daily use. By “notebook” what is meant is a reporter’s notebook. The blog aims to make use of those interesting tidbits of the sort found in a reporter’s notebook but might not fit neatly in the print edition of C&EN for one reason or another.
The Editors’ Blog by Rudy M. Baum and A. Maureen Vorhi
There’s nothing cute about the name of this blog or its contents. The only thing to note about the title is that “Editors” is plural, as both Rudy M. Baum, C&EN editor-in-chief, and A. Maureen Rouhi, C&EN deputy editor-in-chief, will host it.
The content you can always expect to find here is the current week’s editorial. We hope readers will use the Editors’ Blog to add their own point of view on the topic being discussed in the editorial. We’ll do our best to respond to comments as they come in. Occasionally, we’ll post an additional entry during the week when something of interest comes to our attention.
The Haystack by Lisa Jarvis and Carmen Drahl
C&EN editors Lisa Jarvis and Carmen Drahl weed through pharma’s molecular mountain to pluck out the drug developments worth noting. Coverage spans science and business context for drug industry news; spotlights on academic and industry conferences; interview outtakes and updates from drug discovery features in C&EN’s pages; and the employment prospects for chemists working in life sciences.
The Safety Zone by Jyllian Kemsley and Jeff Johnson
The Safety Zone covers chemical safety issues in academic and industrial research labs and in manufacturing. The blog is a place for exchange and discussion of lab and plant safety and accident information without the fanfare of a news article. The lead writers are C&EN associate editor Jyllian Kemsley and senior correspondent Jeff Johnson. The blog also includes contributions from other C&EN staff writers as well as health and safety experts in academia, corporations, and government.
I’m delighted to join this fantastic group of writers and will focus on the chemistry aspects of natural products – from prescription and OTC drugs to herbal and non-botanical supplements.
My initial welcome post at the CENtral Science home of Terra Sigillata provides the backstory on my move to my chemistry roots.
I apologize for moving again about a month after leaving ScienceBlogs but I’m grateful that you chose to follow me here. I hope that you’ll join me over at CENtral Science.
These are interesting times. The diaspora from ScienceBlogs and mergers with indie bloggers has brought together new partnerships, such as Scientopia, and strengthened existing ones, such as Lab Spaces.
To help you keep track of these networks, Dave Munger, Anton Zuiker, and Bora Zivokvic launched this week an aggregator of science blogging networks called – no surprise – scienceblogging.org. Many thanks to these fine North Carolina gents for including CENtral Science among their featured networks.
The discerning science connoisseur have more and more choices out there and we appreciate your readership. The next time your leisure reading calls for a science blog, I hope that you’ll consider joining us at CENtral Science, the new home of Terra Sigillata.
Bora Zivkovic, DrugMonkey, and I have been really impressed by this idea by the online folks over at the American Chemical Society’s Chemical & Engineering News. This week, their blog network, CENtral Science, has been promoting their presence at the upcoming national ACS meeting in Boston.
Folks may not know this but ACS is the largest professional scientific society in the world with 161,000 members.
DrugMonkey, the king of science blogging schwag, has previously mentioned the benefits of such a promotion several times to another science blogging network but it never got traction with the powers-that-be. But here’s the idea from CENtral Science – from this post:
Here’s how to win:
*While supplies last
CONTEST RULES: This promotion is ONLY valid from 8/15 to 8/24. A total of 350 t-shirts will be given out (one per person) from 9:00 a.m. through 5:00 p.m. on 8/23 and 8/24 at booth #527 in the expo hall only. To receive a t-shirt each individual must present all 6 (correct) key words. Winners must be ACS members to participate. ACS staff and their families are not eligible. All gift card recipients must be wearing a CENtral Science t-shirt. There is no guarantee of winning any prize. Gift card winners will be chosen at random every half hour during published expo times.
Now THAT’s how you do it.
You have to read the blogs to pick up each of the six keywords.
Three hundred and fifty T-shirts. 350!
And you wear them at the meeting.
And they give away a $50 $10, $25, or $50 gift cards every half hour for two days.
The T-shirt is very nice, by the way, and I’m grateful to C&EN Online editor, Rachel Pepling (Twitter) for sending me one. I will be wearing it for our panel discussion on Tuesday! Rachel’s also a Gator so she gets even more favor points from me.
Once again, hunt me down in Boston if you’d like to say hello. I’ll be the one in the yellow CENtral Science T-shirt.
Warning: rare self-indulgent post.
Blogging has been and will be light over the next few days while we are packing up things around here to move to our next, more permanent home.
In the meantime, you may have noticed here and on Twitter that part of my big news is that I will begin writing under my PharmMom-given name.
My dilemma has been that I have two Twitter accounts. @AbelPharmboy has been the one I use for all blog-related stuff as well as any other gems of my mind that can fit into 140 characters. Thanks to you, I have 1,600 followers at that account. However, I also have a real name Twitter account that I used for my now-fledgling-and-almost-nonexistent music career and local banter with folks in the Durham-Chapel Hill area. That one only had 200 followers until I began announcing my metamorphosis.
With the pending blog move and melding of my IRL and online identities, one of my mentors, Twitter follower, writer, editor, and Johns Hopkins journalism professor, Mary Knudson, asked what I was going to do regarding the two avatars I use for each Twitter account.
One of my dear friends was enthusiastic about me coming up with a new avatar for the real name account but I’ve been worried about losing old followers who might not recognize the real name avatar.
Here is my metamorphosis:
More news on our move as it becomes available.
I’m really excited to be going up to Boston for a few days next week to attend the fall meeting of the American Chemical Society.
Besides presenting some of our collaborative work, the highlight of my time there will be with Carmen Drahl of C&EN and The Haystack blog hosting a panel on chemistry and pharmaceutical blogging. The session will be held 12 noon – 2 pm on Tuesday, August 24 with Derek Lowe (In the Pipeline), Ed Silverman (Pharmalot), Michael Tarselli at Scripps Florida, and your humble correspondent.
Here’s the description from Carmen:
These folks will each give a short talk, but the real highlight here is the panel. I’d love for people to show up with great questions. Want to talk about how blogs are playing a role in discussing layoffs and employment? How about the trickiness to promoting new drugs on the web? Or what role new media should have in critiquing papers? The panel’s as good a time as any to bring those issues up.
I’ll be moderating the event, which is slated for Tuesday, August 24, from 12 noon till 2PM in the Boston Convention Center, Ballroom West.
It costs $16 to sign up for the session, which includes lunch. You can register for the event at the main ACS meeting registration site here. It is listed as the MEDI Lunch and Learn/Ticket No. SE 19.
Get more information about the event from this promo flyer.
I’ll be honest with you folks – I’m peeing my pants with anticipation.
Derek Lowe is the grand master of pharma blogging. Derek is a medicinal chemist who has somehow managed to write from the standpoint of a pharmaceutical industrial chemist and give us insights that you’ll rarely find elsewhere in the blogosphere. In fact, it was an interview with Derek in The Scientist in August 2005 that led me to start this blog. Derek does us a great service in academia by helping our trainees learn what it’s like to work inside a drug company, a place that about half of my trainees and fellow Ph.D. students now work. The 52 posts in his “Academia vs. Industry” category is a great place to start reading.
Ed Silverman is the go-to writer for coverage of the pharmaceutical industry, at least on this side of the pond (hello, Pharmagossip!). I respect a lot of other pro writers and bloggers on that beat such as Matthew Herper at Forbes and Scott Hensley when he was at the Wall Street Journal Health Blog, but now editor of NPR’s Shots health blog.
But Ed wrote for many years at the newspaper of my childhood, the Newark Star-Ledger, at a time when I dreamed of working for a northern New Jersey pharmaceutical company. With 75% of US pharmaceutical companies having a presence within 150 miles of Newark, Ed was at the heart of the business and told it like it is. In the new home of Pharmalot with Canon Communications, he continues to provide cutting edge news on the drug industry and current legal actions in the community. Ed’s off on summer break right now but will return in time for our talks and panel discussions.
I haven’t met Michael Tarselli yet but I’m excited to do so and learn about the Scripps presence in Jupiter, Florida, where I have a few old colleagues. I’ve already been fortunate to meet Carmen, a Princeton-trained PhD chemist-turned journalist – Bora Zivkovic has a nice interview with her from ScienceOnline2010.
For those of you who won’t be there, Carmen is asking folks to send in questions for the panel via this survey form.
I want to ask Derek how in the heck he got the okay to blog from the highly risk-averse environment of a pharmaceutical company and how he approached this when a plant closure required that he find another position. Did his blogging help him drum up prospects and did his ultimate employer view his visibility as a blogger as a plus?
And in the wake of the Pepsigate exodus from ScienceBlogs, what is the place for writing about being a scientist in industry without being a pawn of one’s employer? I think that it’s essential for there to be just as much blogging by industry scientists as by academics and professional science writers. In chemistry, it seems to be much more accepted that one will work in a corporation (my data-free impression only). But our fellow scientists trained in pharmacology, genetics, or molecular biology have just as much opportunity to work in industry, large and small. Why aren’t we doing more in the blogosphere to prepare our trainees for these opportunities?
What would you like to see discussed at this panel? Drop a line in the comments or go over to Carmen’s response page.
And if you’re in Boston, please come say hello!